Latest filing published 29 Dec 2025 for Pelthos Therapeutics Inc..
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew J. Einhorn: trading record in brief
Andrew J. Einhorn is a declared insider at 3 companies (finance chief); the most frequent names are PDS Biotechnology Corp, RVL Pharmaceuticals plc and Pelthos Therapeutics Inc. The record holds 16 filings, for trades running from 6 October 2015 to 23 December 2025.
Purchases make up the whole of the open-market record (1 purchase, €439k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 8 share grants.
On 29 December 2025 came the latest disclosure, a share grant in Pelthos Therapeutics Inc. The last insider purchase was made public on 8 October 2015, 4,050 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew J. Einhorn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,000 sharesCommon StockSEC:0001753926-25-001991:0
- 9,607 shares@ US$1.13100.0% of flowOrdinary SharesSEC:0001104659-22-007844:0
- 6,467 shares@ US$3.12100.0% of flowOrdinary SharesSEC:0001104659-21-069879:0
- 9,668 shares@ US$4.4629.6% of flowOrdinary SharesSEC:0001104659-21-007785:0
- 71,550 shares0Ordinary SharesSEC:0001104659-20-064440:0
- 9,184 shares@ US$7.0069.1% of flowOrdinary SharesSEC:0001104659-20-008837:0
- 104,849 shares0Ordinary SharesSEC:0001104659-19-003723:0
- 1,567 shares@ US$2.39100.0% of flowCommon StockSEC:0001127602-17-011377:0
- 10,443 sharesCommon StockSEC:0001140361-15-037183:0
- 4,747 sharesCommon StockSEC:0001140361-15-037183:1
- 24,089 sharesCommon StockSEC:0001140361-15-037183:2
- 2,377 shares@ US$6.79Common StockSEC:0001140361-15-037183:3
- 15,720 sharesCommon StockSEC:0001140361-15-037183:4
- 21,221 sharesCommon StockSEC:0001140361-15-037183:5
- 45,000 shares@ US$11.00Common StockSEC:0001140361-15-037183:6Canonical exit: 4 Jan 2016 (T+90)
- 1,651 shares@ US$7.75Common StockSEC:0001140361-15-037183:7
16 of 16 declarations
